Showing results (971-980 of 2,915) with videos related to

Sort By:
Pageof 292
Cancer Gene Therapy|July 27, 1999
Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanomaJ Nemunaitis, T Fong, J M Robbins, et al.
Cancer Gene Therapy|July 27, 1999
Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transferO N Koç, J S Reese, E M Szekely, et al.
Cancer Gene Therapy|July 27, 1999
DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in miceF Neglia, A M Orengo, M Cilli, et al.
Cancer Gene Therapy|July 27, 1999
Inhibitory effect on the establishment of hepatic metastasis by transduction of the tissue plasminogen activator gene to murine colon cancerS Hayashi, I Yokoyama, Y Namii, et al.
Cancer Gene Therapy|September 7, 2000
Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybridsM Athanasiou, L LeGallic, D K Watson, et al.
Cancer Gene Therapy|October 7, 2000
P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patientsJ L Boulay, A P Perruchoud, J Reuter, et al.
Cancer Gene Therapy|October 7, 2000
Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growthI Campbell, A Magliocco, T Moyana, et al.
Cancer Gene Therapy|August 5, 2000
Adenovirus-mediated N5 gene transfer inhibits tumor cell proliferation by induction of apoptosisS Yin, M C Hung, D W Goodrich
Cancer Gene Therapy|December 23, 1999
Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cellsP M Duque, C Alonso, R Sánchez-Prieto, et al.
Cancer Gene Therapy|June 1, 2000
Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cellsC Lechanteur, M Moutschen, F Princen, et al.
Pageof 292